Reply to M. Wissing et al

Affiliations

Comment

Lisette M Wiltink et al. J Clin Oncol. 2017.

. 2017 Jun 1;35(16):1862.

doi: 10.1200/JCO.2017.72.6125. Epub 2017 Mar 13.

¹ Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Carien L. Creutzberg, and Cornelia A.M. Marijnen, Leiden University Medical Center, Leiden, the Netherlands.

No abstract available

Comment on

No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials.
Wiltink LM, Nout RA, Fiocco M, Meershoek-Klein Kranenbarg E, Jürgenliemk-Schulz IM, Jobsen JJ, Nagtegaal ID, Rutten HJ, van de Velde CJ, Creutzberg CL, Marijnen CA. Wiltink LM, et al. J Clin Oncol. 2015 May 20;33(15):1640-6. doi: 10.1200/JCO.2014.58.6693. Epub 2014 Dec 22. J Clin Oncol. 2015. PMID: 25534376
Postoperative Pelvic Radiotherapy in Patients With Endometrial Cancer May Increase the Risk for Secondary Pelvic Cancers: A Post Hoc Analysis of Results From the TME, PORTEC-1, and PORTEC-2 Trials.
Wissing MD, Azoulay L. Wissing MD, et al. J Clin Oncol. 2017 Jun 1;35(16):1861-1862. doi: 10.1200/JCO.2017.72.6497. Epub 2017 Mar 13. J Clin Oncol. 2017. PMID: 28549230 No abstract available.